Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

12

Revenue 2014

Amgen

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Amgen's 2013 sales performance.

Medicxi aims to plug funding gap for European biotech

Medicxi aims to plug funding gap for European biotech

like US companies Amgen, Genentech or Gilead - all too often promising projects and innovation leak away to other regions.

FDA fast-tracks Pfizer and Lilly's tanezumab

FDA fast-tracks Pfizer and Lilly's tanezumab One competitor - Amgen - has been developing its own candidate called fulranumab, but former partners Johnson &Johnson and Takeda handed back rights to the project last year. ... The drug does not feature in Amgen's pipeline chart. Meanwhile Pfizer and

Pfizer gets FDA panel recommendation for biosimilar EPO

Pfizer gets FDA panel recommendation for biosimilar EPO Amgen reported Epogen sales of $1.3bn last year – all from the US market – while Procrit earned $1.1bn for J&J, including $767m from the US. ... The notification – which kicks off a 180-day stay on a launch – should only kick in after FDA approval

Sanofi/Regeneron's Sarilumab cleared by FDA on second attempt

Sanofi/Regeneron's Sarilumab cleared by FDA on second attempt s Humira (adalimumab) and Amgen's Enbrel (etenercept).

Lilly set to head to regulators with CGRP migraine drug

Lilly set to head to regulators with CGRP migraine drug Lilly set to head to regulators with CGRP migraine drug. Gathers three positive late-stage trials of galcanezumab as it chases Amgen. ... Three positive phase III trials put Eli Lilly on course to file its CGRP inhibitor galcanezumab later this year, as

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical

Porterhouse Medical provides medical and scientific communication services to the pharmaceutical industry across the globe, with a focus on programmes...

Latest intelligence

The new pharma marketing playbook
Learn about the 5 areas that must be in your pharma marketing playbook...
Pharma needs to evolve from customer-centricity to stakeholder-centricity
Customer-centricity and patient-centricity is no longer enough for pharma sales and marketing strategies as digital promises better customer experiences for all pharma stakeholders....
5 health behavioural factors to incorporate in your marketing
Achieve real health behaviour change by including these elements in your pharmaceutical marketing....

Infographics